Bilateral subtrochanteric femoral fractures in a previous alendronate-medicated patient: a case report
Jacob J Triplet,1 Timothy Hawkes,2 Sein Lwin2
1Nova Southeastern University, College of Osteopathic Medicine, Fort Lauderdale, FL, USA; 2Broward Health Medical Center, Orthopedic Surgery Residency Program, Fort Lauderdale, FL, USA
Abstract: Bisphosphonate therapy is commonly employed in the management of osteoporosis. Several drug-associated adverse events are well established but are often not considered in patients who have discontinued therapy. Here, we present the case of a patient who sustained bilateral atypical subtrochanteric fractures 1 year after discontinuation of long-term bisphosphonate therapy. We discuss the prodromal clinical presentations and the importance of radiographic imaging to investigate impending fractures. The treatment of these fractures included the implementation of a drug holiday and the use of intramedullary nail stabilization.
Keywords: bisphosphonate, femur, osteoporosis, prophylactic stabilization
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]